PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children and ...
To recruit and retain clinicians in a competitive market, some communities make the case that rural practice can restore what ...
As the South continues its rise as the destination for tech companies, a new study shows two cities in the Triangle are ...